The PE ratio for Embecta stock stands at 13.01 as of Jul 25, 2024. The calculation is based on the latest EPS of $1.22 and the stock price of $15.87 per share. A decrease of 23% has been observed in the PE ratio compared to its average of 16.8 of the past four quarters.
Over the last three years, the average PE ratio of Embecta has been 13.07. The current 13.01 price-to-earnings ratio is in line with the historical average. Analyzing the last three years, EMBC's PE ratio reached its highest point in the Jun 2023 quarter at 24.55, with a price of $21.6 and an EPS of $0.88. The Jun 2022 quarter saw the lowest point at 4.24, with a price of $25.32 and an EPS of $5.97.
Maximum annual increase: 66.76% in 2023
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 12.24 | 66.76% |
| 2022 | 7.34 | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| EMBC Embecta Corp | 12.76 | $897.93M |
| OFIX Orthofix Medical Inc | N/A | $619.61M |
| NVRO Nevro Corp | N/A | $357.74M |
The price to earnings ratio for EMBC stock is 13.01 as of Jul 25, 2024.
The highest quarterly PE ratio in the last three years has been 24.55 and it was in the Jun 2023 quarter.
EMBC's current price to earnings ratio is 0.5% below its 3-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 25, 2024), Embecta's share price is $15.87. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $1.22. Therefore, Embecta's price to earnings ratio for today is 13.01. PE RATIO(13.01) = STOCK PRICE($15.87) / TTM EPS($1.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.